Sapheon received $19.8 million from investors to further develop a device that injects an adhesive into varicose veins to seal them. After a small incision, an ultrasound is used to guide a catheter to the affected vein, which is treated with drops of the glue. Post-treatment medication and compression garments are not needed, the company says. A pivotal study could be completed next summer.

Full Story:

Related Summaries